Aberrant Super‐Enhancer Landscape in Human Hepatocellular Carcinoma
Author:
Affiliation:
1. State Key Laboratory of Liver Research (The University of Hong Kong) and Department of Pathology, Li Ka Shing Faculty of Medicine The University of Hong Kong Hong Kong China
Funder
Health and Medical Research Fund
Publisher
Wiley
Subject
Hepatology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.30544
Reference38 articles.
1. Molecular therapies and precision medicine for hepatocellular carcinoma;Llovet JM;Nat Rev Clin Oncol,2018
2. Transcriptional addiction in cancer;Bradner JE;Cell,2017
3. Hallmarks of cancer: the next generation;Hanahan D;Cell,2011
4. The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update;Liu M;Protein Cell,2014
5. Super‐enhancers in the control of cell identity and disease;Hnisz D;Cell,2013
Cited by 81 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Discovery of Novel PROTAC Degraders of p300/CBP as Potential Therapeutics for Hepatocellular Carcinoma;Journal of Medicinal Chemistry;2024-02-05
2. The P53-P21-RB1 pathway promotes BRD4 degradation in liver cancer through USP1;Journal of Biological Chemistry;2024-02
3. Prognostic and predictive value of super-enhancer-derived signatures for survival and lung metastasis in osteosarcoma;Journal of Translational Medicine;2024-01-22
4. Co-overexpression of BRD4 and CDK7 promotes cell proliferation and predicts poor prognosis in HCC;Heliyon;2024-01
5. Super-enhancers and the super-enhancer reader BRD4: tumorigenic factors and therapeutic targets;Cell Death Discovery;2023-12-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3